Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. This change does not affect study details, eligibility criteria, outcomes, or other user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section now lists Michigan as a study site under Locations. The footer text changed by removing 'HHS Vulnerability Disclosure' and 'Michigan Locations' and the revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check46 days agoChange DetectedA new revision tag v3.3.2 was added and the previous v3.3.1 tag removed, indicating a minor version update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a note in the Publications section stating that PubMed publications are automatically filled and may not pertain to the study, added a Revision: v3.3.1, and removed the older PubMed description and Revision: v3.2.0 text; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedNotice about government funding lapse was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe two screenshots show only minor UI tweaks with no changes to core study content, eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.